MRI Criteria for Adenomyosis with Abnormal Uterine Bleeding
In a reproductive-age woman with adenomyosis and abnormal uterine bleeding, pelvic MRI is indicated when transvaginal ultrasound incompletely visualizes the uterus or endometrium, or when initial imaging findings are indeterminate. 1
Primary Indications for MRI
When Ultrasound Fails to Adequately Assess the Endometrium
The ACR Appropriateness Criteria clearly establish that adenomyosis itself is a key reason why the endometrium cannot be completely evaluated by ultrasound 1. The presence of adenomyosis, particularly when coexisting with leiomyomas, significantly limits transvaginal ultrasound's ability to visualize the endometrium completely. MRI becomes the appropriate next step because:
- Multiplanar capability allows visualization of the endometrium even when obscured by adenomyosis 1
- Superior tissue contrast resolution distinguishes endometrial pathology from surrounding myometrial disease 1
- Sensitivity of 78% and specificity of 93% for diagnosing adenomyosis itself 1
Critical Clinical Scenarios Requiring MRI
Order MRI when any of these apply:
Incomplete endometrial visualization on transvaginal ultrasound due to:
Indeterminate ultrasound findings requiring further characterization 1
Persistent abnormal bleeding despite negative initial ultrasound, especially when endometrial cancer risk factors exist 1
Pre-treatment assessment when planning fertility-preserving interventions or uterine artery embolization 1
MRI Protocol Requirements
When ordering MRI, specify:
- Gadolinium-based IV contrast (preferred) 1
- Diffusion-weighted imaging sequences (strongly recommended) 1
The diffusion-weighted sequences are critical because they improve sensitivity and specificity for detecting malignant pathology, with area under the curve of 0.89 for differentiating benign from malignant endometrial disease 1. This is particularly important given MRI's ability to detect endometrial cancer with sensitivity up to 79% and specificity up to 89% 1.
What MRI Accomplishes That Ultrasound Cannot
MRI provides critical information for morbidity and mortality risk stratification:
- Excludes endometrial malignancy with high accuracy even when adenomyosis obscures the endometrium on ultrasound 1
- Differentiates leiomyosarcoma from benign leiomyomas (100% sensitivity and specificity) 1
- Identifies irregularity of the endometrial-myometrial interface and abnormal diffusion signal—the most helpful features for detecting malignancy 1
- Accurately maps adenomyosis extent and location for surgical planning 1
Common Pitfalls to Avoid
Do not order MRI as initial imaging—transvaginal ultrasound with Doppler remains first-line 1. The ACR explicitly states there is no relevant literature supporting MRI for initial evaluation of abnormal uterine bleeding 1.
Do not skip endometrial sampling when indicated by risk factors, even if MRI is planned 1. MRI complements but does not replace tissue diagnosis when endometrial cancer risk is elevated.
Do not order MRI without specifying contrast and diffusion-weighted sequences—these are essential for detecting malignancy and should be "strongly considered" per ACR guidelines 1.
Clinical Algorithm
For a reproductive-age woman with known adenomyosis and abnormal uterine bleeding:
- Start with transvaginal ultrasound (with Doppler)
- If endometrium incompletely visualized or findings indeterminate → Order MRI pelvis with contrast and diffusion-weighted imaging
- If endometrial cancer risk factors present → Consider endometrial sampling regardless of imaging findings
- If persistent bleeding despite negative workup → MRI appropriate for surveillance and reassessment 1
The key distinction is that adenomyosis itself creates the indication for MRI by limiting ultrasound's diagnostic capability, particularly for excluding life-threatening endometrial pathology that would impact mortality 1.